{
    "nctId": "NCT00637026",
    "briefTitle": "Ph II Early BC Pre-Surgical Biologic Study",
    "officialTitle": "A PreSurgical Study to Evaluate Molecular Alterations That Occur in Human Breast Cancer Tissue and Normal Skin After Short Term Exposure to ZD1839 (IRESSA) and to Correlate These Alterations With Pharmacokinetic Parameters.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 65,
    "primaryOutcomeMeasure": "Molecular alterations occuring in breast cancer tissue following Iressa treatment",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Invasive breast cancer, Aged 18 years or older, Not more than 28 days from initial diagnosis\n\nExclusion Criteria:\n\n* Pregnant or lactating patients, Prior or current radiotherapy for breast cancer, Known allergy reaction to Iressa",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}